Irwin Naturals, Inc.

OTCPK:IWIN.Q Stock Report

Market Cap: US$749.6k

Irwin Naturals Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Klee Irwin

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.2yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Klee Irwin's remuneration changed compared to Irwin Naturals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

-US$20m

Jun 30 2023n/an/a

-US$19m

Mar 31 2023n/an/a

-US$13m

Dec 31 2022US$306kUS$295k

-US$4m

Sep 30 2022n/an/a

US$4m

Jun 30 2022n/an/a

US$3m

Mar 31 2022n/an/a

US$6m

Dec 31 2021US$259kUS$248k

US$9m

Sep 30 2021n/an/a

US$7m

Jun 30 2021n/an/a

US$11m

Mar 31 2021n/an/a

US$10m

Dec 31 2020US$75kUS$69k

US$7m

Compensation vs Market: Insufficient data to establish whether Klee's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Klee's compensation has increased whilst the company is unprofitable.


CEO

Klee Irwin (58 yo)

3.2yrs

Tenure

US$305,593

Compensation

Mr. Klee Irwin is Chairman and Chief Executive Officer at Irwin Naturals Inc and is its Director since August 2021. He has been Chief Executive Officer and President of Omni Nutraceuticals since March 12,...


Board Members

NamePositionTenureCompensationOwnership
Klee Irwin
Chairman & CEO3.2yrsUS$305.59kno data
Lyle Maxson
Directorless than a yearno datano data
Luke Lokhorst
Directorless than a yearno datano data

0.7yrs

Average Tenure

Experienced Board: IWIN.Q's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.